1-[(2,4-dimethoxyphenyl)methyl]-4-(1-hydroxy-1-methyl-ethyl)pyrrolidin-2-one
|
P681800-5g
|
≥97% |
2891598-04-0 |
5g
|
¥ 24800.9
|
期货,请咨询 |
阿拉丁 |
1-[(2,4-dimethoxyphenyl)methyl]-4-(1-hydroxy-1-methyl-ethyl)pyrrolidin-2-one
|
P681800-500mg
|
≥97% |
2891598-04-0 |
500mg
|
¥ 5280.9
|
期货,请咨询 |
阿拉丁 |
1-[(2,4-dimethoxyphenyl)methyl]-4-(1-hydroxy-1-methyl-ethyl)pyrrolidin-2-one
|
P681800-25g
|
≥97% |
2891598-04-0 |
25g
|
¥ 80000.9
|
期货,请咨询 |
阿拉丁 |
1-[(2,4-dimethoxyphenyl)methyl]-4-(1-hydroxy-1-methyl-ethyl)pyrrolidin-2-one
|
P681800-250mg
|
≥97% |
2891598-04-0 |
250mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
1-[(2,4-dimethoxyphenyl)methyl]-4-(1-hydroxy-1-methyl-ethyl)pyrrolidin-2-one
|
P681800-1g
|
≥97% |
2891598-04-0 |
1g
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
1-[(2,4-dimethoxyphenyl)methyl]-4-(1-hydroxy-1-methyl-ethyl)pyrrolidin-2-one
|
P681800-10g
|
≥97% |
2891598-04-0 |
10g
|
¥ 42160.9
|
期货,请咨询 |
阿拉丁 |
1-[(2,4-dimethoxyphenyl)methyl]-4-(1-hydroxy-1-methyl-ethyl)pyrrolidin-2-one
|
P681800-100mg
|
≥97% |
2891598-04-0 |
100mg
|
¥ 2000.9
|
期货,请咨询 |
阿拉丁 |
potassium salt;trifluoro(spiro[2.5]oct-6-en-6-yl)boranuide
|
P681771-500mg
|
≥97% |
N/A |
500mg
|
¥ 8960.9
|
期货,请咨询 |
阿拉丁 |
potassium salt;trifluoro(spiro[2.5]oct-6-en-6-yl)boranuide
|
P681771-250mg
|
≥97% |
N/A |
250mg
|
¥ 6400.9
|
期货,请咨询 |
阿拉丁 |
potassium salt;trifluoro(spiro[2.5]oct-6-en-6-yl)boranuide
|
P681771-1g
|
≥97% |
N/A |
1g
|
¥ 12800.9
|
期货,请咨询 |
阿拉丁 |
potassium salt;trifluoro(spiro[2.5]oct-6-en-6-yl)boranuide
|
P681771-100mg
|
≥97% |
N/A |
100mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
2-(5-bromopyrazin-2-yl)propan-2-ol
|
P681720-5g
|
≥97% |
1303967-23-8 |
5g
|
¥ 28800.9
|
期货,请咨询 |
阿拉丁 |
2-(5-bromopyrazin-2-yl)propan-2-ol
|
P681720-500mg
|
≥97% |
1303967-23-8 |
500mg
|
¥ 6400.9
|
期货,请咨询 |
阿拉丁 |
2-(5-bromopyrazin-2-yl)propan-2-ol
|
P681720-250mg
|
≥97% |
1303967-23-8 |
250mg
|
¥ 3840.9
|
期货,请咨询 |
阿拉丁 |
2-(5-bromopyrazin-2-yl)propan-2-ol
|
P681720-1g
|
≥97% |
1303967-23-8 |
1g
|
¥ 9600.9
|
期货,请咨询 |
阿拉丁 |
2-(5-bromopyrazin-2-yl)propan-2-ol
|
P681720-10g
|
≥97% |
1303967-23-8 |
10g
|
¥ 48000.9
|
期货,请咨询 |
阿拉丁 |
2-(5-bromopyrazin-2-yl)propan-2-ol
|
P681720-100mg
|
≥97% |
1303967-23-8 |
100mg
|
¥ 2304.9
|
期货,请咨询 |
阿拉丁 |
2-(tert-butoxycarbonylamino)-3-(1H-indazol-5-yl)propanoic acid
|
P681676-5g
|
≥97% |
1628604-25-0 |
5g
|
¥ 28752.9
|
期货,请咨询 |
阿拉丁 |
2-(tert-butoxycarbonylamino)-3-(1H-indazol-5-yl)propanoic acid
|
P681676-500mg
|
≥97% |
1628604-25-0 |
500mg
|
¥ 6416.9
|
期货,请咨询 |
阿拉丁 |
2-(tert-butoxycarbonylamino)-3-(1H-indazol-5-yl)propanoic acid
|
P681676-25g
|
≥97% |
1628604-25-0 |
25g
|
¥ 96016.9
|
期货,请咨询 |
阿拉丁 |
2-(tert-butoxycarbonylamino)-3-(1H-indazol-5-yl)propanoic acid
|
P681676-250mg
|
≥97% |
1628604-25-0 |
250mg
|
¥ 4480.9
|
期货,请咨询 |
阿拉丁 |
2-(tert-butoxycarbonylamino)-3-(1H-indazol-5-yl)propanoic acid
|
P681676-1g
|
≥97% |
1628604-25-0 |
1g
|
¥ 9584.9
|
期货,请咨询 |
阿拉丁 |
2-(tert-butoxycarbonylamino)-3-(1H-indazol-5-yl)propanoic acid
|
P681676-10g
|
≥97% |
1628604-25-0 |
10g
|
¥ 48000.9
|
期货,请咨询 |
阿拉丁 |
2-(tert-butoxycarbonylamino)-3-(1H-indazol-5-yl)propanoic acid
|
P681676-100mg
|
≥97% |
1628604-25-0 |
100mg
|
¥ 2688.9
|
期货,请咨询 |
阿拉丁 |